YouTuberStocks DE
YouTuberStocks / Exelixis

Should I Buy Exelixis (EXEL)? Finance YouTuber Analysis

Exelixis logoEX
Exelixis · EXEL 1 channels
0Score Buy

Price action & creator signals

$53.13 -0.69%
EXEL · NasdaqGS
Buy call Tap the chart to see who made the calls
$53.50 $34.54 Jun 25 Dec 25 Jun 26
52W range
21.56 – 53.50
Volume
—
YouTubers
1
Analysis quality
70

Who's calling it?

View all ↓
CreatorSignalPrice targetDate
FINANZFOKUSFIFINANZFOKUS Buy —
Rank on YouTuberStocks #294 of 595 · best #13
#1 #595 Jul 25 Jun 26

What the YouTubers say

FINANZFOKUSFI
FINANZFOKUSBuyConviction3/5Analysis quality70/1001

The YouTuber intends to build a small position in Exelixis due to its strong position in the oncology market, particularly with its kidney and liver cancer drug Carbomatics, which holds a 44% market share. A recent patent victory protects Carbomatics from generic competition until 2030. The company is also investing heavily in new therapies like Saner Linenip, which shows promising early results and could generate significant future revenue. Strong revenue growth of 24.49% and expected EPS growth of over 31% make it an attractive entry point despite reliance on a single drug.

BUY FINANZFOKUS Conviction3/5 Analysis quality70/100 now

The YouTuber intends to build a small position in Exelixis due to its strong position in the oncology market, particularly with its kidney and liver cancer drug Carbomatics, which holds a 44% market share. A recent patent victory protects Carbomatics from generic competition until 2030. The company is also investing heavily in new therapies like Saner Linenip, which shows promising early results and could generate significant future revenue. Strong revenue growth of 24.49% and expected EPS growth of over 31% make it an attractive entry point despite reliance on a single drug.

“Deshalb plane ich im Juli eine kleine Position aufzubauen.” — ▶ Watch clip

FINANZFOKUS →

Why you can trust the ranking

No hype, no cherry-picking — just qualified calls, weighed evenly across every creator we track.
1

Only qualified calls

A named stock, a clear buy or sell stance, and real reasoning. Passing mentions and hype are filtered out.

2

One vote per creator

Each channel counts once per stock, so a single loud voice can't skew the ranking.

3

Weighted consensus

We weigh how many creators agree, how convinced they are, and how recent each call is.

Open the Terminal →

FAQ

Should I buy Exelixis?

1 finance YouTubers analysed Exelixis with qualified reasoning — consensus: Buy, average analysis quality 70/100. This is not financial advice; review the individual analyses and sources above.

Are finance YouTubers bullish or bearish on Exelixis?

Among the channels covering Exelixis, 1 are buying and 0 are selling or avoiding — overall Buy.

How do you decide what to include for Exelixis?

Only qualified analyses count: a clear buy/sell stance on Exelixis with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.

Which YouTubers cover Exelixis?

FINANZFOKUS

More stocks in the ranking

Amazon · AMZNMeta · METANvidia · NVDAGoogle Alphabet · GOOGLMercado Libre · MELIShopify · SHOPBroadcom · AVGOSoFi · SOFI